Dr. Megha Prasad, MD

Dr. Prasad practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Prasad's NPI, 1174887137, was assigned on June 25, 2012. Dr. Prasad graduated from Keck School of Medicine of USC in 2012. Dr. Prasad's New York license number on file is 292520.

Dr. Prasad's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Prasad's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Prasad is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Prasad to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Prasad practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Prasad's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Prasad is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Prasad's licenses on file in 2 states: New York and Minnesota.

Dmand AI lists angioplasty, cardiac catheterization, chronic hypertension, circulation problems, coronary artery disease, heart blockage, heart valve disorders and high cholesterol among the conditions Dr. Prasad treats.

CMS data shows 846 Medicare services from Dr. Prasad across 11 procedure codes in 2024, for 375 Medicare patients. Medicare paid $123,493 for them.

CMS counts 375 Medicare patients who saw Dr. Prasad in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 34% are also on Medicaid. Their average risk score is 5.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Prasad's median patient age at 66, with 33% women.

In 2024, Dr. Prasad wrote 176 Medicare Part D claims for 63 patients. 57% of them were for generic drugs. CMS names the drug for 52 of them, across 2 drugs with 11 or more claims each, at $51,260 in total drug cost. In 2023, CMS named 333 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Prasad for performance year 2024, reported through an alternative payment model (APM). Dr. Prasad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Prasad as offering telehealth. CMS counts 21 procedures of coronary angioplasty and stenting by Dr. Prasad, more than 52% of the clinicians it reports for that procedure.

Dmand AI links 88 papers to Dr. Prasad, published from 2011 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Coronary Angiography, Coronary Artery Disease and Coronary Vessels. Dr. Prasad has published most often in Mayo Clin Proc. Dr. Prasad's most frequent co-authors are Jeffrey Warren Moses, MD, Martin Bert Leon, MD and Rajiv Gulati, MD.

Dmand AI links Dr. Prasad to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Coronary Vasospasm and Microvascular Angina.

CMS Open Payments shows 719 general payments to Dr. Prasad from 36 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. Chiesi USA, Inc. paid the most, $177,134.

Dr. Prasad graduated from Keck School of Medicine of USC in 2012.

Dr. Prasad is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.